Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2
COVID-19 (coronavirus disease 2019) is caused by a new positive-strand RNA coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), […]
A team of scientists in Israel recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2 (also […] New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus […] The body's immune response plays a crucial role in the course of a SARS-CoV-2 infection. In addition to antibodies, the […] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. To date, […] SARS-CoV-2 genome is three times larger than influenza genome. Both consist of NRA molecules that mutate when replicate. It is […] Researchers in the United States and Canada have conducted a study showing that just a single dose of either the […] The new coronavirus rapidly spreading in China and nearby countries seems to trigger symptoms similar to those seen in the […]SARS
Data from Israel’s vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response
New COVID-19 variants can evade antibodies that work against original form of the virus
SARS-CoV-2 can evade immune response by T-killer cells through mutations
Corticosteroid receptor inhibitor shows anti-SARS-CoV-2 activity in vivo
New tool enables study of SARS-CoV-2 mutant spectrum by ultrasequencing
Both mRNA vaccines protect against emerging variants of SARS-CoV-2
First clinical studies find Wuhan virus closely resembles SARS